Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors

Gautam K. Sahu, Miles W. Cloyd

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Recently, there is considerable interest in the field of anti-HIV therapy to identify and develop chromatin-modifying histone deacetylase (HDAC) inhibitors that can effectively reactivate latent HIV in patients. The hope is that this would help eliminate cells harboring latent HIV and achieve an eventual cure of the virus. However, how effectively these drugs can stimulate latent HIVs in quiescent primary CD4 T cells, despite their relevant potencies demonstrated in cell line models of HIV latency, is not clear. Here, we show that the HDAC inhibitors valproic acid (VPA) and trichostatin A (TSA) are unable to reactivate HIV in latently infected primary CD4 T cells generated in the H80 co-culture system. This raises a concern that the drugs inhibiting HDAC function alone might not be sufficient for stimulating latent HIV in resting CD4 T cells in patients and not achieve any anticipated reduction in the pool of latent reservoirs.

Original languageEnglish (US)
Article number400
JournalVirology Journal
Volume8
DOIs
StatePublished - 2011

Fingerprint

Histone Deacetylase Inhibitors
HIV
T-Lymphocytes
trichostatin A
Histone Deacetylases
Valproic Acid
Coculture Techniques
Pharmaceutical Preparations
Chromatin
Viruses
Cell Line

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors. / Sahu, Gautam K.; Cloyd, Miles W.

In: Virology Journal, Vol. 8, 400, 2011.

Research output: Contribution to journalArticle

@article{c31b3a8cd8764285845aff918f80609d,
title = "Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors",
abstract = "Recently, there is considerable interest in the field of anti-HIV therapy to identify and develop chromatin-modifying histone deacetylase (HDAC) inhibitors that can effectively reactivate latent HIV in patients. The hope is that this would help eliminate cells harboring latent HIV and achieve an eventual cure of the virus. However, how effectively these drugs can stimulate latent HIVs in quiescent primary CD4 T cells, despite their relevant potencies demonstrated in cell line models of HIV latency, is not clear. Here, we show that the HDAC inhibitors valproic acid (VPA) and trichostatin A (TSA) are unable to reactivate HIV in latently infected primary CD4 T cells generated in the H80 co-culture system. This raises a concern that the drugs inhibiting HDAC function alone might not be sufficient for stimulating latent HIV in resting CD4 T cells in patients and not achieve any anticipated reduction in the pool of latent reservoirs.",
author = "Sahu, {Gautam K.} and Cloyd, {Miles W.}",
year = "2011",
doi = "10.1186/1743-422X-8-400",
language = "English (US)",
volume = "8",
journal = "Virology Journal",
issn = "1743-422X",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors

AU - Sahu, Gautam K.

AU - Cloyd, Miles W.

PY - 2011

Y1 - 2011

N2 - Recently, there is considerable interest in the field of anti-HIV therapy to identify and develop chromatin-modifying histone deacetylase (HDAC) inhibitors that can effectively reactivate latent HIV in patients. The hope is that this would help eliminate cells harboring latent HIV and achieve an eventual cure of the virus. However, how effectively these drugs can stimulate latent HIVs in quiescent primary CD4 T cells, despite their relevant potencies demonstrated in cell line models of HIV latency, is not clear. Here, we show that the HDAC inhibitors valproic acid (VPA) and trichostatin A (TSA) are unable to reactivate HIV in latently infected primary CD4 T cells generated in the H80 co-culture system. This raises a concern that the drugs inhibiting HDAC function alone might not be sufficient for stimulating latent HIV in resting CD4 T cells in patients and not achieve any anticipated reduction in the pool of latent reservoirs.

AB - Recently, there is considerable interest in the field of anti-HIV therapy to identify and develop chromatin-modifying histone deacetylase (HDAC) inhibitors that can effectively reactivate latent HIV in patients. The hope is that this would help eliminate cells harboring latent HIV and achieve an eventual cure of the virus. However, how effectively these drugs can stimulate latent HIVs in quiescent primary CD4 T cells, despite their relevant potencies demonstrated in cell line models of HIV latency, is not clear. Here, we show that the HDAC inhibitors valproic acid (VPA) and trichostatin A (TSA) are unable to reactivate HIV in latently infected primary CD4 T cells generated in the H80 co-culture system. This raises a concern that the drugs inhibiting HDAC function alone might not be sufficient for stimulating latent HIV in resting CD4 T cells in patients and not achieve any anticipated reduction in the pool of latent reservoirs.

UR - http://www.scopus.com/inward/record.url?scp=80051588783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051588783&partnerID=8YFLogxK

U2 - 10.1186/1743-422X-8-400

DO - 10.1186/1743-422X-8-400

M3 - Article

C2 - 21838863

AN - SCOPUS:80051588783

VL - 8

JO - Virology Journal

JF - Virology Journal

SN - 1743-422X

M1 - 400

ER -